This week, the FDA opened applications for its Expedited IND Pilot, quality experts presented at the PDA/FDA Joint Regulatory Conference, and Hovione expanded its spray drying capacity.
|Videos|June 2, 2023
Interview with BioVectra’s Marc Sauer at DCAT
Author(s)Biovectra
KEY LEARNING OBJECTIVES
- BIOVECTRA is a global CDMO with a 52 year history – and a one stop shop for our clients.
- Our growth, in recent years, has been explosive and we’ve made big moves into biologics in recent years. Our new mRNA and Biomanufacturing facility opens later this year and just adds one more capability to our menu.
- We are a trusted partner for our clients. Our tagline of “We Care” came from focus group with clients who have time and again chosen us over competitors because of the service we provide.
Related to this article
Christy Owings, Thermo Fisher, explains clinical trial supply chain risks in Latin America, importer-of-record strategy, AI, and eCOA delays.
PharmTech AI Pulse Check debuts: pharma experts tackle GxP 'slop,' multi-agent validation risk, OCR document mining, personalized mRNA cancer therapy.
Andrea K. Kerrigan, FDA, outlines how validation, data integrity, and QRM determine whether digital tools and AI strengthen or undermine CGMP compliance.
PharmTech spoke with Tara Dougal, event director for pharma at Informa Markets, about trends impacting the pharmaceutical industry and how CPHI Milan is addressing these areas this year.
Andrew Parker, PhD, executive drug development consultant, Quotient Sciences, explains how AI is integrated into pharmaceutical development.
PDA/FDA 2026 session maps the GMP audit lifecycle, root cause to CAPA closure, plus a local vs. above-site decision framework and two case studies.
The recently opened NJ spray drying facility doubles capacity for amorphous solid dispersions, addressing solubility limits in roughly 70% of small-molecule pipelines.